Source has listed three of its largest ETPs on the Amsterdam section of the EURONEXT stock exchange.
Source has listed three of its largest ETPs on the Amsterdam section of the EURONEXT stock exchange. The firm writes that this should make it easier and cheaper for local investors to trade and settle the three products.
The USD3 billion Source S&P 500 UCITS ETF has an ongoing charge of 0.05 per cent per annum, offering exposure to US equities; the Source NASDAQ Biotech UCITS ETF is the only ETF in Europe that provides targeted exposure to the US biotechnology segment; and the Source Physical Gold ETC is the largest Source product, currently with more than USD3.4 billion of assets invested, backed by physical gold bullion.
“Investors who are looking for the most effective way to get exposure to a basic benchmark, such as the S&P 500, are increasingly turning to ETFs,” says Source’s Sjef Pieters. “They generally have low costs, trade throughout the day, and many often provide very accurate tracking of the index.”
Pieters continues: “Trump’s election victory triggered demand in these three areas of the market, with some investors thinking his growth plans will help US companies either broadly or in certain sectors such as biotech. At the same time, we have seen others wanting to add gold in case uncertainty or volatility escalates.”